MSA Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
MSA Advisors's LLY Position: Q1 2026 in Review
MSA Advisors increased its Eli Lilly (LLY) stake by 150% in Q1 2026, buying an estimated $3.8M and bringing the position to 6,248 shares worth $5.75M. The position accounts for 1.73% of the portfolio, ranked #11.
MSA Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- MSA Advisors held 6,248 shares of Eli Lilly worth $5.75M as of Q1 2026.
- MSA Advisors bought 3,748 Eli Lilly shares in Q1 2026, an estimated $3.8M.
- Eli Lilly made up 1.73% of MSA Advisors's portfolio in Q1 2026, its #11 holding.
- MSA Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on MSA Advisors's 13F filing for Q1 2026, filed 18 May 2026.